Med-X, Inc. is in live offering mode and is actively accepting Title IV investments.
$420.00 minimum investment

Med-X, Inc.

Educate, Innovate, Cultivate

Large OPO
Canoga Park, CA
Accepting International Investment
Play video

Med-X, Inc. is an innovator and leader in developing all-natural and alternative solutions to the outdated poisonous chemicals and harmful pharmaceutical products often used in pest control and pain management. Med-X incorporates best-in-class science and technology for manufacturing, and service capabilities across pest control, pain management, aromatherapy and essential oil product development. Commercial sales and third-party service providers are represented and managed through various domestic and international distribution partners. Retail sales are currently conducted by over-the-counter pharmacy retailers and various commerce service providers. 

Med-X is a leader in green technology manufacturing that will lead to the benefit of our shareholders and partners, while also helping consumers and communities find solid solutions to achieve and live a healthy lifestyle without the concern of personal and environmental impact. 

Med-X is further developing and expanding its digital media platform, The Marijuana Times. Med-X is developing cannabis-related products in a legal and eco-friendly fashion throughout 2018 and beyond. 

Inform and engage the public using digital media. Cannabis industry media is distributed via web content via the web, mobile applications, and produced and shared social platforms like Apple News, Youtube, Apple Podcast and other social media outlets. 

Through The Marijuana Times, Med-X aims to educate and provide thoughtful and engaging content directly for the cannabis community.

Develop all-natural and alternative solutions to the outdated poisonous chemicals and harmful pharmaceutical products often used in pest control and pain management.

Med-X innovates, researches, and develops a variety of natural products that provide safe alternatives to consumers. These “Green” product lines include Nature-Cide, Thermal-Aid, Home Spa and Maliblu Brands.

Research and grow medicinal cannabis for testing and ancillary product development.

With patient care in mind first, Med-X's cultivation lab conducts research and grows medicinal cannabis in various potencies for testing. We aim to ensure that cannabis grown for medical or recreational use is as safe as possible. Nature-Cide is planning to enter the legal cannabis cultivation arena as soon as federal law permits. 

The legalization of recreational/medical cannabis is taking over the United States. Multiple states have seen massive tax gains from legalizing recreational use while medical system states continue to be a model for other states around the country. More than half of the states in the US have some medical marijuana legislation.

As more states legalize medical and recreational cannabis, the demand for Med-X's quality products is growing. Innovation is where Med-X excels,

and Med-X consumer-ready products support the expansion of the industry.

State by state, new requirements for contaminant testing and product potency are affecting cultivators who handle pests and molds with harmful and toxic treatments of the past. As laws remove harmful and poisonous pesticides from the cultivation facilities and require nontoxic treatments, Nature-Cide is positioned to become an industry standard for organic pest control management.

Until the industry receives federal recognition and official legislation, patients, and cannabis users are exposed to products that have been cultivated using the ways of the past and by cultivators interested inquantity over quality. Until there is a federal regulatory body for medical cannabis, patients, and recreational users have no way to know where their product comes from or whether or not it was treated with toxic pest repellents. Patients using strains that have been treated with Med-X’s Nature-Cide green pest-control products will know their medicine is safe, even without a government stamp.

The cannabis industry has tremendous potential and our products are ready for cultivators who are looking to meet growing demand. With the commercial pest control, hospitality and janitorial venues using and recommending Nature-Cide nationally, Med-X has created a perfect jump-off point into cannabis cultivation. Management's track record with product development coupled with multiple national distribution relationships presents the opportunity for success.

Now is a great time to consider investing in Med-X as we are positioned to embrace and benefit from the booming cannabis industry as well as other emerging alternative markets transitioning to green technology like the pain management and pest control industries. Ballots are heating up all over the U.S. with cannabis laws, new businesses are sprouting up to provide products and supplies, and we believe we have the tools to capitalize on the massive growth of all of these industries industry. 

The devastating effects of the opioid crisis is forcing the pharmaceutical and health care industries to take a step back and look for safer options that deliver the same results for managing pain. 

Regulations make it more difficult than ever to introduce new synthetic chemical pesticides products to the market. A total social acceptance transformation is in the making in regards to folks understanding the risks and dangers associated with using chemicals in agriculture and the home. 

Make history and join, Med-X as we take these industries by storm. Thanks to the rapid growth of the cannabis industry and other green technology industries, new trends have developed to better support this growth.

Multi-state licensing is crucial to national cannabis brands finding lasting success. States are beginning to require product potency and contaminant testing to ensure consumer safety, and new laboratories are emerging to meet these needs. In 2017 Med-X released a Pest Control Cultivation Report.

2017 Nature-Cide Cannabis Cultivation Report

The landscape of cultivation is changing as licensed facilities grow in size and numbers to meet the booming medical and recreational demand for cannabis.

Cannabis cultivation materials, supplies, and medical research are deemed to grow into billion dollar industries on their own in a matter of years.

Our media magazine, The Marijuana Times, will draw advertisers and partners to this space in a market where many outlets block the promotion of cannabis related ads.

Our research and development of medical grade strains and potencies will play a long-term role in the business model and eventually distribute cannabis to the medical community.

Med-X is poised to compete in the market with a tested and proven green alternative to pest control, that will meet the new state licensing standards. Cultivation centers and growers will be required to follow guidelines to deploy products such as Nature-Cide Insecticides.

The industry is expanding. We have the right products, the right timing, and the right team in place to maximize our impact. We are first in the cannabis sector to bring this opportunity to the people.

Disrupting an industry, educating the public, and providing safe, effective patient care is our mission. We are working to make the world a better place through each and every division of our company. And that is why we are going to be a smart investment.

We are scientists, doctors, and passionate business professionals who want to help the world and provide cleaner, safer, and more effective ways to reap the many benefits of medical cannabis.

Med-X, Inc. is already working on various stages of automation that will change the cannabis market forever and you can be a part of it today.

All Economic Value details, including future projections, employment numbers and or statistics, are sourced from The Marijuana Business Fact Book. Produced by the Marijuana Business Daily. Industry and revenue statistics are sourced from the ArcView Market Research Report.

What is Reg A+ Equity Crowdfunding?

In June 2015, the final Regulation A+ rules under Title IV of the JOBS Act of 2012 became effective, after approval by the Securities and Exchange Commission, paving the way for companies like Med-X, Inc. to raise up to $50 million from both accredited and non-accredited investors.

Med-X, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).







Nature-Cide Ships First Order to Mumbai India

16 days ago

This week, our pest control division, Nature-Cide shipped it's first order to our distribution partner, Rentokill in Mumbai, India. Our continued expansion into Asian markets exemplifies the increased need for effective and safe pest control options as more countries overseas continue to restrict the use of dangerous chemicals that tend to have long-lasting negative human and environmental impacts. 

With the addition of India, the Nature-Cide product line is currently in use in the United States and Hong Kong. The next slated rollouts will be to Malaysia and Macau. As we move forward into 2018 we intend to continue to scale up operations bringing Nature-Cide to Europe, and South America. 

This was also a big week for the media division, The Marijuana Times. The team was able to come to an agreement with a mainstream ComScore Top 5 ad network partner. This arrangement puts the digital publication in a unique place as one of the only major Cannabis Media outlets to be serving mainstream digital advertising. 

The team is hopeful that with this new revenue stream the publication will continue to grow its audience and have more flexibility to market itself as one of the premier cannabis news outlets.

Thanks for your interest and continued support.

Matthew Mills
President & Founder | Med-X, Inc.

Med-X, Inc. will not be Affected Adversely by Attorney General Jeff Sessions Rescission of the Cole Memo

about 2 months ago

LOS ANGELES, According to AP reports, Attorney General Jeff Sessions has rescinded the Cole Memo, which was the Obama administration's protection of state-compliant cannabis businesses that allowed for the legal cannabis industry to flourish across the country.

"Given the immediate and extensive backlash from politicians across both parties, the fact that over 70% of the country is in favor of legalized marijuana and that this action only gives the Federal government discretion to prosecute, we do not see any adverse material impact to our core businesses. It's full steam ahead for Med-X." states Med-X, Inc. Founder and President Matthew Mills.

The recent Sessions memo states that the "Memorandum is intended solely as a guide."  Thus, it is not a directive and simply allows U.S. prosecutors considerable leeway in their enforcement decisions. According to Mills, Med-X firmly believes that the likelihood of widespread federal prosecutions against marijuana companies operating legally in their State is minimal. "In fact, Federal prosecuting of individuals and companies operating outside the bounds of State law is very likely to lead to higher levels of compliance and accountability within the industry, which will be beneficial to everyone in the long haul."   

According to Mills, "At this time Med-X's core business consists of an ancillary cultivation products supplier, an information network with The Marijuana Times. and completing a merger with an affiliated company with non-cannabis revenue. We do not cultivate or distribute marijuana at the present time." 

Recently Med-X announce its plan to acquire Pacific Shore Holdings, Inc. which positions Med-X with two new revenue generating divisions. The Nature-Cide division is in the fast paced all natural "Green" pest control arena with pest control services and products. "Currently Nature-Cide products are distributed and positioned nationally through Target Specialty Products distribution centers. The highly effective all-natural Nature-Cide product line is utilized by licensed pest control operators nationally for residential and commercial applications in places like hotels, school districts, hospitals, zoos and various other applications, where using traditional chemical pest control applications is just not acceptable anymore," states Mills. 

The second revenue source will be the  Thermal-Aid division, which consists of pain relief products which are distributed by Independence Medical and Cardinal Health distribution venues and are supported by national programs such as Flexible Spending Accounts for patients nationally.  In addition, there are other products on the horizon.

As explained by Med-X, Inc. Chief Executive Officer, Dr. David Toomey, "As we have been working to perfect our work in blending essential oils for natural pest control applications for the last couple of years, no one realizes that these same blending techniques have been utilized in our Pain Management product development. This has allowed Med-X to create Hemp oil derived blends for products to combat such issues as migraine headaches as well as joint and muscle pain. The first pain relief cream product was created for the clinically proven Thermal-Aid Headache Relief System and has morphed into a proprietary essential oil blend which includes Hemp oil pain relief cream product, that we expect to release in the second quarter of 2018."

"Overall, in spite of Attorney General Sessions recent actions, we are very optimistic about the cannabis sector and Med-X's current and future revenue streams." stated Mills.

Med-X, Inc. Cautionary Statement Regarding Forward Looking Statements
There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+  Offering Circular.

Med-X, Inc. Enters into Merger Acquisition Agreement Capturing Multiple Revenue Streams

2 months ago

Happy Holidays to everyone from the Med-X, Inc. team. Today we also have a very important announcement to make. Please see the news below. It has been a big year for us. Management is very proud of our team and we are very excited for what 2018 will bring. 

Matthew Mills | President and COO

LOS ANGELES, Dec. 22, 2017/ -- Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have entered into a definitive merger and acquisition agreement ("Agreement").  Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine with PSH, a global green pest control company and Over the Counter ("OTC") pharmacy products supplier. This business combination will create a leader in the development of commercial and consumer products, integrated pest management services and pain management solutions. The merger is expected to close during the first quarter of 2018.

To read the details of the transaction visit Med-X SEC 1-U Filing dated 12-21-17

Under the terms of the Agreement, PSH shareholders will tender two shares of common stock, in exchange for one share of Med-X common stock. The terms have been unanimously approved by both companies' Boards of Directors. 

To facilitate this transaction, Med-X majority shareholder, President and COO Matthew Mills will surrender approximately 79% of his Med-X common stock ownership. This combined with the 10% outstanding Med-X shares owned by PSH will facilitate the exchange. Once this transaction is complete with all of the PSH shareholders, Med-X shareholders will not experience any dilution with their current holdings. Upon closing of the merger, Mr. Mills will then hold approximately 14% of the outstanding common stock of the combined company. Mr. Mills will remain in control of the combined company with the issuance of preferred stock which will have only voting share rights. This will allow senior management and the Board of Directors to maintain control of the company after the merger.

"The proposed combination of Med-X and PSH represents the next stage of our continued growth to become a global leader in green medicine technologies," stated Dr. David E. Toomey, Chief Executive Officer, Med-X, Inc. "With its international and domestic distribution partnerships in place, PSH aligns with and enhances the Med-X cannabis platform and further positions all of our business divisions for global growth. Through this transaction, we will also expand our ability to further invest in or acquire other companies in the space, develop new innovative solutions for customers and increase shareholder value," stated Dr. Toomey.

"We expect this transaction, combined with our growth plans for 2018 and beyond, to propel the combined company forward.  It should also fuel our continued efforts with our Regulation A+ Crowdfunding initiative, which allows everyday Americans to participate with an investment of $420 for 700 shares in the company. This transaction should offer greater value to our shareholders, customers and employees as well open some doors within the investment banking community," explains, Med-X, Inc. President and Chief Operating Officer, Matthew Mills.

Under the terms of the proposed transaction, the businesses of Med-X and PSH will be combined under Med-X which will retain the name, "Med-X, Inc." Upon the closing of the transaction, the combined company is expected to maintain Med-X's legal domicile and headquarters in Canoga Park, CA.


The combined company brings together best-in-class product, technology and service capabilities across media, pest control, pain management, aromatherapy and essential oil manufacturing. As a leader in Green Medicine technologies, ultimately the combined company strives to help its customers achieve a higher quality of life with safe and responsible tools to do so. Sales will be conducted by various means including, international commercial distribution, OTC pharmacy retailers, ecommerce, and third-party service providers. The combination of Med-X and PSH creates immediate opportunities for near-term growth through enhancing the existing product lines and services to the growing legal cannabis market and cross-selling them through our currently established media network, in hopes to expand the global reach for the already established brands.

The newly merged company will also benefit by combining trade secrets and essential oil blending techniques for new products, advanced service solutions already proven effective in other industries, and value-added assets like patents, trademarks, intellectual properties and connectivity with mainstream distributors like Cardinal Health, Independence Medical, Target Specialty Products and Rentokil. As a result, the new company will be able to better partner with its customers inside the legal cannabis market to help improve their overall performance and operations, enhancing the experience for their own customers in areas such as health and wellness, potentially helping patients experience a better quality of life. In addition, the combined company will position a large licensed pest control network, of trained professionals ready to serve the expanding regulated global cannabis cultivation market.

Med-X is in the midst of a resurgence as a thought leader in the cannabis space, especially in regard to exposing certain blemished areas of the industry such as the widespread unregulated pesticide use by cultivators, and the dangerous health impacts of consuming products with high levels of synthetic chemicals. In continuing to expand industry awareness, the company announced in December of 2017, that it plans to scale up and continue expanding its media network division, The Marijuana Times to help promote industry leaders who deserve to be recognized for their hard work, and healthy contributions to the transforming legal cannabis industry.

PSH has transformed from a diversified holding company to a streamlined operating company with a focused and leading green products portfolio in pest control, pain management and healthy living manufacturing. PSH combines its best-in-class products with its first-class reputation and customer support. The company's core strengths include essential oil blending and manufacturing, advanced integrated pest management, pain management solutions as well as world-class branding and marketing.

Value for Shareholders

The Management Team of Med-X and PSH consist of the same Executive personnel. The Boards of Directors consist of the same members except for one director of PSH who will be joining the combined company's Board of Directors upon the closing. This positions the combined company to not miss a step in growing the overall business of the below mentioned divisions.

Prior to the closing, Unaudited Consolidated Pro-Forma Financials prepared by Management, which are subject to change due to the audit, are anticipated to reflect double digit revenue growth. Pro-Forma revenue grew on a consolidated basis of approximately $485,000.00 for fiscal year 2016 to approximately $590,000.00 for fiscal year 2017. In addition, the Pro-Forma consolidated balance sheet is estimated to reflect assets approaching the $2 million threshold. These factors seemingly position the combined company to continue to pursue entry into the public market. Currently the company Auditors (MJF & Associates, APC) for Med-X and PSH are conducting the required annual audits. Once the Audits are concluded, a consolidated Audit Report will be issued for the merged Company.

Upon the closing of the merger, the following divisions will be recognized under the combined companies, Med-X, Inc.'s portfolio:

Nature-Cide - Natural Insecticides / Pesticides developed and deployed in commercial pest control, janitorial, hospitality and agriculture including cannabis cultivation. Distributed globally by Target Specialty Products and Rentokil.

Nature-Cide Cultivation - Large scale, regulated cannabis cultivation and cultivation services and solutions in California.

Thermal-Aid - Natural heating and cooling modalities for pain management for the entire family. Distributed domestically by Cardinal Health and Independence Medical.

The Marijuana Times - Global digital media news network.

Maliblu Brands - Organic Cannabis & Hemp derived products developed for a variety of medical conditions, including but not limited to pain Management, PTSD and sleep disorders.

Home Spa Products - Aromatherapy spa products for personal use.

About Med-X, Inc.

Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced emerging cannabis industry through such activities as compound identification and extraction of the identified cannabidiol (CBD) compounds for the present medical industry demand. The company's digital magazine, The Marijuana Times, publishes quality media content for the medical cannabis community to generate revenue from advertisers as well as sell industry related merchandise to consumers. The Company has been in product development for a number of years, and is ready to bring various products to market in the cannabis pain management, agricultural and ancillary services industries through manufacturing partnerships such as Nature-Cide. For more information regarding Med-X, Inc. and its divisions, please visit,,, email or call 818-349-2870.

About Pacific Shore Holdings, Inc.

PSH produces various products like the scientifically proven all natural and effective Nature-Cide insecticides, pesticides and repellant products that evolved from its Nature-Cide Pest Management Service division. PSH is also known for its clinically proven Thermal-Aid hot and cold pain management modalities products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. For more information about Pacific Shore Holdings, Inc. and its divisions, please visit Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System,, email or call 818-998-0996.

No Offer or Solicitation Securities

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.

Med-X, Inc. Cautionary Statement Regarding Forward Looking Statements

There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.

Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304
(818) 349-2870




SOURCE Med-X, Inc.; Pacific Shore Holdings, Inc.

The Marijuana Times Gets Approval to Publish on Apple News

3 months ago

Canoga Park, CA - Med-X, Inc.’s, The Marijuana Times continued to broaden it’s reach this week. On Thursday, the editorial team received a confirmation letter indicating that Apple had reviewed it's application and approved it’s Apple News channel. Apple iPhone users can now stay up to date via the IOS Apple News App.

“We are starting to see more leniency when it comes to Marijuana Industry content being allowed across non-cannabis information platforms,” said Editor-in-Chief, Nick Phillips. “This is important because we are getting closer and closer to the day when major, non-cannabis advertisers will enter the cannabis space. When that day happens, we will be ready.”

You can find the channel by searching the Keywords, “Marijuana Times,” in the Apple News app or clicking the link below while using your iPhone.

“2018 is going to be a big year for us,” explained, Nick. “Going into the new year we will be publishing daily, original content across several digital platforms including, web, Native IOS, Youtube Video, Apple Podcast Audio and now Apple News. We are in a wonderful position to keep scaling this up.”

As a leader in Cannabis Industry news, The Marijuana Times is looking forward to continuing to educate the community, build up its social media presence, break more stories and bring on board more industry thought leaders and reporters.

For more information on how to become a part of The Marijuana Times, email us at You can stay up to date on all of the platforms through the links below.


IOS App:


Apple Podcast:

Apple News:

Med-X, Inc.’s The Marijuana Times Launches Daily Video News Program

3 months ago

Canoga Park, CA – The Med-X, Inc. management team is proud to announce the launch of The Marijuana Times Show, a daily video show, and Apple podcast. The team at The Marijuana Times continues to present itself as a leading authority in the cannabis industry news sector. The show was developed and launched in order to increase its contributors’ visibility and offer its readers more digital options to stay up to date on everything happening in the cannabis industry.

Hosted by cannabis media veteran, Joe Klare, the video show is produced and aired daily broadcasting the most up to date information as it happens. “Our readers and now viewers wanted more options. In today’s world, it is important to broadcast your message in as many ways as possible. We feel that the video show and podcast is the natural, next evolution of The Marijuana Times,” explained Joe Klare.

The show can be viewed daily on the publication’s Youtube channel, streamed from the website, as well as watched and/or listened to on Apple Podcast. As a subscriber, the viewers of The Marijuana Times Show can now go about their lives and stay up to date at the same time.

Med-X, Inc.’s COO, Matthew Mills is pleased with the growth and progress the digital publication has made over the past few years. “We started this because we thought there needed to be a place where people of all knowledge levels could get information to help progress the industry. Our writers and team have done a stand-up job reporting and planting The Marijuana Times as a leader in this industry. We started with a website, added an IOS app and now we have a daily video and podcast to continue to expanding our reach and touching new readers.” said Mills.

The new programming also offers The Marijuana Times partners more opportunities to advertise their products and services. The team at Med-X, Inc. and The Marijuana Times aim to continue their quest to spread the truth about cannabis as well as develop new and innovative ways to reach people at the same time.

To subscribe to the show’s Youtube channel please visit,

The show can also be found on Apple Podcast as well as watched directly from the website.

For information on how you can be a part of the show email us at

Management is Proud to Announce that we have Officially Raised Over $1M Total from over 900 Investors as of this Week

4 months ago

Everyone on the team would like to thank all of our investors for their support as it has been one heck of an adventure to get here.

We are still the only non-real estate, ancillary Cannabis company to be Qualified by the SEC to raise capital via Regulation A+.

Nobody who raises money using Regulation A+ says it's an easy task, our journey to get to this point is no different.

We are extremely proud of our team and investors for riding out the SEC suspension with such grace, getting our SEC suspension overturned in a SEC proceeding, a first of it’s kind victory,  and hitting the ground running as soon as we got the all clear to continue our capital raising efforts in September 2017. 

Thank you. Our team is more motivated than ever. 

We wanted to take this time to also update all of our current investors as well as potential investors on the Company. 

Nature-Cide continues to grow as a premiere 25(b) product used globally by commercial and residential pest control operators. The team is winding down a week long trip in Baltimore Maryland at one of the biggest pest control events in the world, PestWorld 2017. 

The Nature-Cide brand has positioned itself as one of the fastest paced and most trusted green pesticide in the pest control industry. Moving forward this impacts Med-X because more cannabis businesses are resorting to using licensed applicators. New regulations on cannabis cultivations / facilities in California and other states require reporting and many cannabis businesses are recognizing that licensed applicators already report to state and county authorities. Using a licensed pest control applicator is the fastest, safest and most efficient way to meet the state pesticide testing requirements for cannabis cultivation.  So, where are cannabis businesses going to find these licensed applicators? Through the Nature-Cide network that we have been building since 2014. 

Applicators who once were only working on commercial agriculture applications are now finding themselves protecting production and cannabis cultivation facilities all over the country. The Nature-Cide products are being used successfully in multiple states and being implemented by licensed pest control operators. 

Temporary Cannabis business licenses are scheduled to be issued to California cannabis companies as of January 1, 2018. All new regulations on pesticides and what can be used on cannabis plants and facilities will then legally go into effect. As part of those regulations no company can apply pesticides and process cannabis goods without going through rigorous testing by state and county inspectors. We are anticipating a major shake up in regards to how cultivators and manufacturers are going to be forced to properly applicate approved pesticides throughout their cultivation production and facilities. The Nature-Cide team has been working around the clock to educate pest control operators to handle the rush of cultivation sites that are going to be forced to comply with these rigorous rules and regulations. 

Our team at Med-X has been working on a video series that walks cultivators and applicators through a detailed step-by-step process that marries applicators and cultivators to be 100% compliant.  This training video series could give cultivators and licenced applicators the tools necessary to avoid all of the pesticide problems that were recognized in Colorado, Oregon and Washington. As an approved product for use on Cannabis cultivations in Washington, Colorado, Oregon and Nevada we anticipate a surge in interest around our education and solutions. 

We have worked hard during the past 10 years to get the Nature-Cide brand in this global positioning and we are seeing the results already on the Cannabis cultivation side. 

Our published 18 month research report proves that growing world class medicinal grade Cannabis without using any chemical pesticides is not only doable but if done right, yields incredible results. Link to Report

California regulators already have some of the toughest agriculture regulations in the world. Adding Cannabis to the mix, we do not see them changing their ways, in fact we anticipate the added responsibility will only increase oversight. We anticipate a lot of changes coming to the California cannabis industry over the next two years as the market matures. 

Med-X, Inc. and The Marijuana Times is hosting and sponsoring a regulatory seminar on October 30, 2017. The seminar will bring together over 70 members of the community including leadership from the Los Angeles County Fire Departments and leadership in the dispensary and extraction sectors to work through and discuss the codes and regulations the County is responsible for drafting. We are very grateful to have been selected to help educate and train the Los Angeles County Fire / Building and Safety Organizations to recognize how cultivation can be safe if done properly.

With over 65% of Los Angeles County and 1 million people residing in the unincorporated areas of the county, these building codes will impact all legal cannabis businesses in the county and safety regulations will impact all legal businesses in their jurisdiction.

Safety presentations and discussions will include: 

  • Building codes for all manufacturing facilities, indoor and outdoor cultivation

  • Extraction facilities safety requirements

  • Water usage, runoff and proper pesticide application requirements

We look forward to continuing to facilitate and bridge the gap with our local leadership and law enforcement with the local leadership in the legal cannabis space who intend to do business in Los Angeles County the correct way. 

The Marijuana Times continues to be a leading voice in the cannabis sector. In November the publication will be launching its first daily video news show. This will give our readers another way to consume daily content and stay up to speed on what is happening in the industry. 

We hope that you found this update as inspiring as we do. Our focus and excitement has never been higher since we embarked on this journey in 2014. We pledge to continue to push for fair, safe access to medicinal Cannabis, give Cannabis companies the tools they require to operate in a safe, responsible manner as well as to educate the public on the truth of what this amazing plant can offer to all of us. 

SEC Legend

The securities offered hereby are highly speculative. Investing in shares of Med-X, Inc. involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if a public market develops following this offering it may not continue. You should read the offering circular before making any investment.


Forward-Looking Statements

This email/letter may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," anticipated,"projected" and "forecasted."  Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company.  Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events. Please refer to the offering circular link.

StartEngine Live Offering FAQs

about 2 years ago


Is there a cost to investing?

No, there is no fee charged to the investor at any point during or after the transaction incurred from the StartEngine platform. You pay only for the number of shares you desire to purchase. However, some banks do charge for wire transfers or international transfers.


Do I have an account?

If you made a reservation for shares, then you do have a StartEngine account as one is required to make a reservation. If you no longer remember the password, you can recover it by going to and entering the email address associated with your StartEngine account. If you did not make a reservation for shares, you will need to create a StartEngine account.


I forgot my password, what do I do?

You can recover your password by going to and entering your email address.  An email with a link allowing you to reset your password and login will be sent to the email address you entered. Click on the link and follow the instructions to reset your password.  If you do not see the reset password email, please check your spam folder to make sure it did not get caught by the spam filter. If you still do not get the email, please contact customer experience at

**Please note if you try to recover your password but have not set up a StartEngine account, you will not receive an email.** 

Who can invest?

Anyone can invest. In a departure from previous investment rules, the SEC now permits Regulation A (also called Reg A+) offerings to take on investors who are non-accredited as well as accredited investors.  An accredited investor is an individual who has a net worth in excess of $1MM (excluding his or her primary residence) or has had an annual income in excess of $200,000 ($300,000 if joint income) for the past two years and reasonably expects that to continue. If you are a non-accredited investor, you may invest but will be limited to investing no more than the greater of 10% of your net worth or 10% of your annual income.

Do I have to invest a specific amount?

No, you may invest any amount as long as you meet the minimum investment amount of $420 AND, if you are a non-accredited investor, the amount you invest does not exceed the greater of 10% of your net worth or 10% of your annual income.  

How much is the minimum investment?

The minimum investment amount for MED-X, INC. is $420 or 700 shares.

What is the price per share?

The price per share for the MED-X, INC. offering is $0.60 per share.

Where can I get the full financial details on the offering?

Please refer to the Offering Circular for information on the offering.  

Can I invest by writing a check?

No, we are not accepting paper checks. Please use the Automated Clearing House (ACH) transfer or wire transfer options which are integrated with the StartEngine platform.

Is using StartEngine the only way to invest in MED-X, INC.’s Reg A+ offering?

Yes, you can only purchase Reg A+ shares in MED-X, INC. through the StartEngine platform.

Can I cancel my investment?

Yes, you can cancel your investment. If you made a mistake, you will have a 24-business hour window to contact live customer service via chat to correct your submission or cancel. 

Live chat customer service hours are as follows:

Saturday - Sunday: closed

Monday - Friday 12pm-8pm EST (9am-5pm PST) 


What documentation/confirmation will I receive for my investment?

Investors will receive a confirmation of their investment and a subscription agreement that has been accepted by MED-X, INC. via email.


Who is FundAmerica and why are they involved?

MED-X, INC. will use FundAmerica Securities, an SEC registered, FINRA member and SIPC insured broker-dealer to oversee and administer the actual financial transactions to comply with state and federal regulatory requirements.

How will I know when my investment funds have been deducted from my account?

Once FundAmerica has processed the investment, funds will be deducted via ACH or through a wire transfer. Your bank account should show a payment to FundAmerica / Alliance Bank.


Help, I’m experiencing a problem or having trouble using the platform to invest!

For assistance with making your investment, please contact StartEngine customer support via email at, live chat on our website by clicking on the green chat widget in the lower right corner.